Teva Pharmaceutical Industries (TEVA) Income from Continuing Operations (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded Income from Continuing Operations of -$576 million in Q2 2026, compared with $281 million a year earlier.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Income from Continuing Operations (2009 - 2026) Analysis & Trends
On a TTM basis, Teva Pharmaceutical Industries' Income from Continuing Operations came in at $696 million as of Jun 30, 2026; for FY2025, it was $1.4 billion.
- Across earlier years, Income from Continuing Operations came in at -$1.96 billion in FY2024, -$617 million in FY2023, -$2.52 billion in FY2022 and $447 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Income from Continuing Operations since Q2 2024.
- Per Business Quant, the preceding three quarters came in at $370 million (Q1 2026), $470 million (Q4 2025) and $432 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn | -576.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -576.00 Mn |
| Mar 31, 2026 | 370.00 Mn |
| Dec 31, 2025 | 470.00 Mn |
| Sep 30, 2025 | 432.00 Mn |
| Jun 30, 2025 | 281.00 Mn |
| Mar 31, 2025 | 220.00 Mn |
| Dec 31, 2024 | -275.00 Mn |
| Sep 30, 2024 | -393.00 Mn |
| Jun 30, 2024 | -876.00 Mn |
| Mar 31, 2024 | 519.00 Mn |
| Dec 31, 2023 | -1.80 Bn |
| Sep 30, 2023 | 76.00 Mn |
| Jun 30, 2023 | -907.00 Mn |
| Mar 31, 2023 | -253.00 Mn |
| Dec 31, 2022 | -1.33 Bn |
| Sep 30, 2022 | 64.00 Mn |
| Jun 30, 2022 | -278.00 Mn |
| Mar 31, 2022 | -973.00 Mn |
| Dec 31, 2021 | -151.00 Mn |
| Sep 30, 2021 | 306.00 Mn |
API Access
Teva Pharmaceutical Industries Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();